Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, the company was a publicly traded company, listed on NASDAQ under the symbol "ACUR".

Property Value
dbo:abstract
  • Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, the company was a publicly traded company, listed on NASDAQ under the symbol "ACUR". (en)
dbo:industry
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 41910481 (xsd:integer)
dbo:wikiPageRevisionID
  • 739863466 (xsd:integer)
dbp:foundation
  • 1935 (xsd:integer)
dbp:location
  • Palatine, Illinois
dbp:products
  • Pharmaceuticals
dbp:revenue
  • US$ .75 million
dbp:tradedAs
  • NASDAQ:ACUR
dct:subject
rdf:type
rdfs:comment
  • Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, the company was a publicly traded company, listed on NASDAQ under the symbol "ACUR". (en)
rdfs:label
  • Acura Pharmaceuticals (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Acura Pharmaceuticals Inc. (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of